News tagged with drug manufacturers
Related topics: centers for disease control and prevention , food and drug administration , health officials , drug
Potential diabetes breakthrough: Researchers discover new hormone spurring beta cell production
Researchers at the Harvard Stem Cell Institute (HSCI) have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes, a metabolic illness afflicting an estimated ...
Medical research
Apr 25, 2013 |
4.9 / 5 (12) |
0
|
Breast stem-cell research: Receptor teamwork is required and a new pathway may be involved
Breast-cancer researchers at the University of Wisconsin-Madison have found that two related receptors in a robust signaling pathway must work together as a team to maintain normal activity in mammary stem cells.
Cancer
May 30, 2012 |
not rated yet |
0
|
Mining information contained in clinical notes could yield early signs of harmful drug reactions
Mining the records of routine interactions between patients and their care providers can detect drug side effects a couple of years before an official alert from the U.S. Food and Drug Administration, a Stanford University ...
Medications
Apr 10, 2013 |
not rated yet |
0
|
Misuse of drug patenting could cost the health system billions
(Medical Xpress)—Companies may be misusing the drug patenting system in order to gain control over high-cost drugs in Australia, research from the Melbourne Law School has found.
Medications
Apr 10, 2013 |
5 / 5 (1) |
0
|
FDA requires lower doses for sleep medications (Update)
(HealthDay)—The U.S. Food and Drug Administration announced Thursday that it is asking manufacturers of sleep medications containing zolpidem—including Ambien—to lower the recommended doses and to provide ...
Medications
Jan 10, 2013 |
not rated yet |
0
The perils of delivering anti-malarial drugs through private sector examined
(Medical Xpress)—Getting high-quality anti-malarial drugs to people in places like Zanzibar and Mozambique is a tricky business.
Medications
Nov 09, 2012 |
not rated yet |
0
|
New federal disclosure law may have little impact on drugs prescribed
A Colorado School of Public Health researcher has found that laws designed to illuminate financial links between doctors and pharmaceutical companies have little or no effect on what drugs physicians prescribe.
Medications
May 29, 2012 |
not rated yet |
0
|
Large study reaffirms H1N1, seasonal flu vaccine safety
Back in spring 2009, the H1N1 influenza virus crossed the U.S. border and raised concerns that it might cause a full-scale epidemic in the fall. The Food and Drug Administration worked with other Health and Human Services ...
Diseases, Conditions, Syndromes
Jul 05, 2011 |
not rated yet |
1
|
Neuroscientists' discovery could bring relief to epilepsy sufferers
Researchers at the University of California, Riverside have made a discovery in the lab that could help drug manufacturers develop new antiepileptic drugs and explore novel strategies for treating seizures associated with ...
Medical research
Jun 21, 2011 |
not rated yet |
1
|
Health industry payment details to be publicly available
(HealthDay)—As part of the National Physician Payment Transparency Program and in compliance with a provision in the Affordable Care Act (ACA), the government will make information about financial relationships ...
Health
May 02, 2013 |
5 / 5 (1) |
0
Fearing abuse, US blocks generic OxyContin (Update)
U.S. health regulators will require generic versions of the best-selling painkiller OxyContin to include recent formulation changes designed to make the pill harder to abuse.
Medications
Apr 16, 2013 |
not rated yet |
1
Drug maker Novartis loses India patent battle (Update)
India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent an updated version of a cancer drug in a landmark decision that health activists say ensures poor patients around the world ...
Medications
Apr 01, 2013 |
5 / 5 (3) |
0
Lung-on-a-Chip wins prize for potentially reducing need for animal testing
In a London ceremony today, Wyss Founding Director Don Ingber, M.D., Ph.D., received the NC3Rs 3Rs Prize from the UK's National Centre for the Replacement, Refinement and Reduction of Animals in Research ...
Medical research
Feb 26, 2013 |
not rated yet |
0
Analysis finds vitamin D potency varies widely in dietary supplements
Vitamin D supplement potency varies widely, and the amount of vitamin D in over-the counter and compounded supplements does not necessarily match the amount listed on the label, according to a research letter published in ...
Health
Feb 11, 2013 |
5 / 5 (2) |
1
Novo Nordisk US shares skid on drug review setback (Update)
Shares of Novo Nordisk tumbled Monday after the Danish drugmaker said U.S. regulators need a new study before they can finish their review of two diabetes treatments, a development that could delay approval for several years.
Other
Feb 11, 2013 |
not rated yet |
0
